These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36385627)

  • 21. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.
    Hawerkamp HC; Dyer AH; Patil ND; McElheron M; O'Dowd N; O'Doherty L; Mhaonaigh AU; George AM; O'Halloran AM; Reddy C; Kenny RA; Little MA; Martin-Loeches I; Bergin C; Kennelly SP; Donnelly SC; Bourke NM; Long A; Sui J; Doherty DG; Conlon N; Cheallaigh CN; Fallon PG
    Front Immunol; 2023; 14():1170012. PubMed ID: 37063871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity.
    Ghaemi A; Roshani Asl P; Zargaran H; Ahmadi D; Hashimi AA; Abdolalipour E; Bathaeian S; Miri SM
    Front Immunol; 2022; 13():974364. PubMed ID: 36159845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
    Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
    Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV.
    Donadeu L; Tiraboschi JM; Scévola S; Torija A; Meneghini M; Jouve T; Favà A; Calatayud L; Ardanuy C; Cidraque I; Preyer R; Strecker K; Lozano JJ; Podzamczer D; Crespo E; Bestard O
    AIDS; 2022 Aug; 36(10):1373-1382. PubMed ID: 35730384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients.
    Pierce CA; Preston-Hurlburt P; Dai Y; Aschner CB; Cheshenko N; Galen B; Garforth SJ; Herrera NG; Jangra RK; Morano NC; Orner E; Sy S; Chandran K; Dziura J; Almo SC; Ring A; Keller MJ; Herold KC; Herold BC
    Sci Transl Med; 2020 Oct; 12(564):. PubMed ID: 32958614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine Response Following SARS-CoV-2 Antigen Stimulation in Patients with Predominantly Antibody Deficiencies.
    Lucane Z; Slisere B; Gersone G; Papirte S; Gailite L; Tretjakovs P; Kurjane N
    Viruses; 2023 May; 15(5):. PubMed ID: 37243231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
    Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
    Front Immunol; 2020; 11():580987. PubMed ID: 33193384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal immunization with lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice.
    Hwang IC; Valeriano VD; Song JH; Pereira M; Oh JK; Han K; Engstrand L; Kang DK
    Microb Cell Fact; 2023 May; 22(1):96. PubMed ID: 37161468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.
    Petrone L; Petruccioli E; Vanini V; Cuzzi G; Najafi Fard S; Alonzi T; Castilletti C; Palmieri F; Gualano G; Vittozzi P; Nicastri E; Lepore L; Antinori A; Vergori A; Caccamo N; Cantini F; Girardi E; Ippolito G; Grifoni A; Goletti D
    Clin Microbiol Infect; 2021 Feb; 27(2):286.e7-286.e13. PubMed ID: 33045370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19.
    Zhang W; Clemens EB; Kedzierski L; Chua BY; Mayo M; Lonzi C; Hinchcliff A; Rigas V; Middleton BF; Binks P; Rowntree LC; Allen LF; Tan HX; Petersen J; Chaurasia P; Krammer F; Wheatley AK; Kent SJ; Rossjohn J; Miller A; Lynar S; Nelson J; Nguyen TH; Davies J; Kedzierska K
    Immunol Cell Biol; 2023; 101(10):964-974. PubMed ID: 37725525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined assessment of S- and N-specific IL-2 and IL-13 secretion and CD69 neo-expression for discrimination of post-infection and post-vaccination cellular SARS-CoV-2-specific immune response.
    Kratzer B; Schlax LC; Gattinger P; Waidhofer-Söllner P; Trapin D; Tauber PA; Sehgal ANA; Körmöczi U; Rottal A; Feichter M; Oberhofer T; Grabmeier-Pfistershammer K; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Mühl B; Kropfmüller A; Negrin B; Kundi M; Valenta R; Pickl WF
    Allergy; 2022 Nov; 77(11):3408-3425. PubMed ID: 35690994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-inflammatory immune profile mediated by TNF and IFN-γ and regulated by IL-10 is associated to IgG anti-SARS-CoV-2 in asymptomatic blood donors.
    Chaves DG; de Oliveira LC; da Silva Malta MCF; de Oliveira IR; Barbosa-Stancioli EF; Teixeira MM; Martins ML
    Cytokine; 2022 Jun; 154():155874. PubMed ID: 35397248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients.
    Lu Q; Zhu Z; Tan C; Zhou H; Hu Y; Shen G; Zhu P; Yang G; Xie X
    Int J Clin Pract; 2021 Sep; 75(9):e14462. PubMed ID: 34107113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy.
    Najafi-Fard S; Petruccioli E; Farroni C; Petrone L; Vanini V; Cuzzi G; Salmi A; Altera AMG; Navarra A; Alonzi T; Nicastri E; Palmieri F; Gualano G; Carlini V; Noonan DM; Albini A; Goletti D
    Front Immunol; 2022; 13():984098. PubMed ID: 36148228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection.
    Albayrak N; Orte Cano C; Karimi S; Dogahe D; Van Praet A; Godefroid A; Del Marmol V; Grimaldi D; Bondue B; Van Vooren JP; Mascart F; Corbière V
    Front Immunol; 2022; 13():769839. PubMed ID: 35422799
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Viurcos-Sanabria R; Manjarrez-Reyna AN; Solleiro-Villavicencio H; Rizo-Téllez SA; Méndez-García LA; Viurcos-Sanabria V; González-Sanabria J; Arroyo-Valerio A; Carrillo-Ruíz JD; González-Chávez A; León-Pedroza JI; Flores-Mejía R; Rodríguez-Cortés O; Escobedo G
    Front Immunol; 2022; 13():897995. PubMed ID: 35860236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients.
    Olea B; Albert E; Torres I; Amat P; Remigia MJ; Gozalbo-Rovira R; Rodríguez-Díaz J; Buesa J; Blasco ML; Redón J; Signes-Costa J; Navarro D
    J Clin Virol; 2021 Sep; 142():104943. PubMed ID: 34391981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.